Sermorelin.com Introduces Physician-Supervised Peptide Therapy Program for Patients Undergoing GLP-1 Treatment
Sheridan, United States – February 27, 2026 / Sermorelin.com /
SHERIDAN, WY – Sermorelin.com, a telehealth platform specializing in physician-supervised peptide therapy, today announced the launch of a new clinical program designed to help patients on GLP-1 receptor agonist medications preserve lean body mass during treatment. The program pairs personalized sermorelin protocols with licensed physician oversight, delivered entirely through the company’s telehealth infrastructure.
An Emerging Clinical Concern
GLP-1 receptor agonists, including semaglutide and tirzepatide, have become among the most widely prescribed medications in the United States for weight management and metabolic health. While these therapies have demonstrated significant efficacy in clinical trials, researchers have identified lean tissue loss as an area of growing clinical interest.
Published research in peer-reviewed journals has noted that a meaningful portion of weight lost during GLP-1 therapy may come from lean body mass rather than fat alone. This has prompted healthcare providers to explore complementary approaches that may support muscle and tissue preservation alongside GLP-1 treatment.
Where Sermorelin Therapy Fits
Sermorelin is a growth hormone-releasing hormone (GHRH) analog that has been studied for its ability to stimulate the body’s natural production of growth hormone. Unlike direct growth hormone administration, sermorelin works through the body’s existing feedback mechanisms, which researchers have noted may offer a differentiated physiological approach.
Sermorelin.com’s new program provides patients with individualized treatment protocols developed by licensed physicians. Each protocol is tailored based on the patient’s clinical profile, health history, current medications, and treatment goals. All consultations, prescriptions, and ongoing monitoring are conducted through the platform’s secure telehealth system.
Program Details
The Sermorelin.com physician-supervised program includes:
- Initial clinical evaluation with a licensed physician via telehealth
- Personalized sermorelin protocol development based on individual patient needs
- Ongoing physician monitoring and protocol adjustments as clinically indicated
- Prescription fulfillment through licensed U.S. compounding pharmacies
- Direct-to-patient delivery with secure packaging
- Educational resources on peptide therapy, lifestyle optimization, and treatment expectations
> “We are seeing meaningful clinical interest in how peptide therapies like sermorelin may complement GLP-1 treatment plans. Our physician-supervised model ensures that every patient receives an individualized protocol rather than a one-size-fits-all approach. The goal is to give patients and their providers another evidence-informed tool in their treatment toolkit.” – Mark Lombardi, Sermorelin.com
Telehealth-First Approach
Sermorelin.com’s platform is designed to make physician-supervised peptide therapy accessible to patients regardless of geographic location. The telehealth model eliminates the need for in-person clinic visits while maintaining direct physician involvement at every stage of treatment.
All prescriptions are fulfilled through licensed compounding pharmacies that operate under applicable state and federal regulations. Sermorelin remains available for prescribing through compounding pharmacies under current regulatory frameworks.
Looking Ahead
Sermorelin.com plans to continue expanding its clinical offerings and educational resources as research in peptide therapy evolves. The company is committed to a physician-first model where all treatment decisions are made by licensed healthcare providers based on individual patient needs.
For more information about Sermorelin.com’s physician-supervised peptide therapy programs, visit https://sermorelin.com.
About Sermorelin.com
Sermorelin.com is a telehealth platform that connects patients with licensed physicians for personalized peptide therapy consultations. The platform specializes in sermorelin and related peptide protocols, offering physician-supervised treatment plans with prescription fulfillment through licensed U.S. compounding pharmacies and direct-to-patient delivery. Sermorelin.com is committed to making evidence-informed peptide therapy accessible, convenient, and physician-guided.
Contact Information:
Sermorelin.com
30 N Gould St Ste R
Sheridan, WY 82801
United States
Mark Lombardi
+1 307-217-6473
https://sermorelin.com
